NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
ORS E-190-2004-0-PCT-02 Apparatus and Method for Decontamination PCT PCT PCT/US2005/037753 Expired
NCI E-186-2005-0-US-01 Angio-inhibitory Peptides Derived From Human TIMP-2 US 60/728,146 Abandoned
NIAID E-114-2006-0-PCT-02 Adenovirus Fiber Shaft Composition And Methods Of Use PCT PCT PCT/US2005/037115 Expired
NIAID E-114-2006-0-EP-04 Adenovirus Fiber Shaft Composition And Methods Of Use EP National Stage 05812347.2 Pending
NIAID E-114-2006-0-CA-03 Adenovirus Fiber Shaft Composition And Methods Of Use CA National Stage 2584639 Abandoned
NHLBI E-114-2004-0-CA-04 Multi-domain Amphipathic Helical Peptides and Methods of Their Use CA National Stage 2584048 Issued
NCI E-249-2005-0-CA-03 Treating or Preventing Renal Cancer Using a Dimethane Sulfonate CA National Stage 2625741 Abandoned
NHLBI E-114-2004-0-JP-06 Multi-domain Amphipathic Helical Peptides and Methods of Their Use JP National Stage 2007-536912 Issued
NCI E-249-2005-0-AU-02 TREATING OR PREVENTING RENAL CANCER USING A DIMETHANE SULFONATE AU National Stage 2005337169 Abandoned
NHLBI E-114-2004-0-AU-03 Multi-domain Amphipathic Helical Peptides and Methods of Their Use AU National Stage 2005295640 Issued
NHLBI E-114-2004-0-ES-13 Multi-domain Amphipathic Helical Peptides and Methods of Their Use ES EP 05815961.7 Issued
NHLBI E-114-2004-0-IT-16 Multi-domain Amphipathic Helical Peptides and Methods of Their Use IT EP 05815961.7 Issued
NHLBI E-114-2004-0-EP-05 Multi-domain Amphipathic Helical Peptides and Methods of Their Use EP National Stage 05815961.7 Issued
NHLBI E-114-2004-0-DE-12 Multi-domain Amphipathic Helical Peptides and Methods of Their Use DE EP 05815961.7 Issued
NHLBI E-114-2004-0-FR-14 Multi-domain Amphipathic Helical Peptides and Methods of Their Use FR EP 05815961.7 Issued
NHLBI E-114-2004-0-GB-15 Multi-domain Amphipathic Helical Peptides and Methods of Their Use GB EP 05815961.7 Issued
NHLBI E-114-2004-0-CH-11 Multi-domain Amphipathic Helical Peptides and Methods of Their Use CH EP 05815961.7 Issued
NCI E-253-2003-1-US-02 Cytotoxic Indeno- And Isoindenoisoquinoline Compounds US National Stage 10/553,532 7312228 Abandoned PDF
NHLBI E-114-2004-0-PCT-02 Multi-domain Amphipathic Helical Peptides and Methods of Their Use PCT PCT PCT/US2005/036933 Expired
NCI E-157-1993-2-US-14 New Procedure to Block the Replication of Reverse Transcriptase Dependent Viruses by the Use of Inhibitors of Deoxynucleotides Synthesis US CON 11/250,899 Abandoned
NHLBI E-114-2004-0-EP-10 Multi-domain Amphipathic Helical Peptides and Methods of Their Use EP DIV 10004512.9 Abandoned
NCI E-249-2005-0-PCT-01 TREATING OR PREVENTING RENAL CANCER USING DIMETHANE SULFONATE PCT PCT PCT/US05/037152 Expired
NIAMS E-028-2006-0-EP-01 A Novel Predictive Marker Of Disease Severity In Inflammatory Diseases EP ORD 05022344.5 Pending
NICHD E-166-2005-0-US-01 Hydropneumatic Pump US 60/726,327 Abandoned
NIA E-243-2005-0-US-01 Susceptibility-matched Plates For High-throughput Screening By Magnetic Resonance Imaging And Spectroscopy US 60/725,299 Abandoned
NCI E-302-2004-0-PCT-02 A32 Mnoclonal Antibody Fusion Proteins for use as HIV Inhibitors and Vaccines PCT PCT PCT/US05/036568 Expired
NCI E-155-2005-2-US-01 Development Of A Vaccine Against Human Papillomavirus (HPV) Using A Variant Of The HPV 16 E2 Protein US 60/724,783 Abandoned
NCI E-075-2000-0-EP-06 NITRIC OXIDE Releasing Metallic Medical Devices EP DIV 05022005.2 Abandoned
NICHD E-107-2003-0-CN-09 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. CN National Stage 200480009311.9 Abandoned
NCI E-340-2004-2-CA-03 Adoptive Immunotherapy with Enhanced T Lymphocyte Survival CA National Stage 2590401 Issued
NCI E-340-2004-2-EP-05 Adoptive Immunotherapy with Enhanced T Lymphocyte Survival EP National Stage 05858553.0 Issued
NCI E-340-2004-2-AU-04 Adoptive Immunotherapy with Enhanced T Lymphocyte Survival AU National Stage 2005336093 Issued
NCI E-340-2004-2-PCT-01 Adoptive Immunotherapy with Enhanced T Lymphocyte Survival PCT PCT COMB PCT/US2005/036407 Expired
NCI E-182-2002-0-US-03 Immunotherapy Regimens in HIV-Infected Patients US National Stage 10/513,257 Abandoned
NINDS E-039-2006-0-US-01 Octanol Formulations And Methods Of Treatment Using The Same US 60/724,635 Abandoned
NCI E-148-2003-0-US-03 GENE EXPRESSED IN PROSTATE CANCER, METHODS AND USE THEREOF US National Stage 10/552,515 7572887 Abandoned PDF
NEI E-328-2004-0-PCT-02 Methods for Treating Active Uveitis PCT PCT PCT/US2005/036125 Expired
NCI E-117-1995-2-JP-07 ANTIVIRAL PROTEINS, DNA-CODING SEQUENCES THEREFOR, AND USES THEREOF JP DIV 293007/2005 Abandoned
NCI E-167-2007-0-US-11 Antigenic Peptides US National Stage 10/529,885 Abandoned
NCI E-323-2004-0-PCT-02 Arylthioindole Tubulin Polymerization Inhibitors and Methods of Treating Or Preventning Cancer Using Same PCT PCT PCT/US05/035896 Abandoned
NCI E-113-2006-0-US-01 Potent Small Molecule (no Peptide) Inhbitors As Therapeutics Against Botulinum Neurotoxins US 60/723,442 Abandoned
NIDDK E-045-2005-2-PCT-01 METHODS OF USING GLYCOSAMINOGLYCANS FOR THE TREATMENT OF KIDNEY DISEASE PCT PCT COMB PCT/US2005/035790 Expired
NIDCR E-079-2007-0-PCT-02 Method Of Improving Drugs With Anti-retroviral And Anti-cancer Activity PCT PCT PCT/US2005/035665 Expired
NIDDK E-045-2005-2-EP-04 METHODS OF USING GLYCOSAMINOGLYCANS FOR THE TREATMENT OF KIDNEY DISEASE EP National Stage 05807269.5 Abandoned
NIDDK E-045-2005-2-AU-02 METHODS OF USING GLYCOSAMINOGLYCANS FOR THE TREATMENT OF KIDNEY DISEASE AU National Stage 2005292202 Abandoned
NIDDK E-045-2005-2-CA-03 METHODS OF USING GLYCOSAMINOGLYCANS FOR THE TREATMENT OF KIDNEY DISEASE CA National Stage 2583079 Abandoned
NIDDK E-045-2005-2-JP-06 METHODS OF USING GLYCOSAMINOGLYCANS FOR THE TREATMENT OF KIDNEY DISEASE JP National Stage 2007-534903 Abandoned
NICHD E-107-2003-0-JP-07 Cholesterol-Containing Compounds and Their Use as Immunogens Against Borrelia Burgdorferi. JP National Stage 2006-509573 Abandoned
NIDDK E-045-2005-2-IL-05 METHODS OF USING GLYCOSAMINOGLYCANS FOR THE TREATMENT OF KIDNEY DISEASE IL National Stage 182353 Abandoned
NIDDK E-324-2004-3-PCT-01 In Vitro Model For Hepatitis C Virion Production PCT PCT COMB PCT/US2005/035487 Expired